08/18/2025
3:00 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/18/2025
3:10 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2025
8:13 PM | ARMISTICE CAPITAL, LLC (Filed by)
Moleculin Biotech (Subject)
| Form SCHEDULE 13G/A | |
08/13/2025
7:05 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2025
3:31 PM | Moleculin Biotech (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/06/2025
7:40 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2025
4:13 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2025
7:35 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2025
7:25 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/11/2025
4:27 PM | Moleculin Biotech (Filer)
| Form 424B5 | |
07/11/2025
4:27 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for MBRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Moleculin Biotech and its competitors with MarketBeat's FREE daily newsletter. |
07/09/2025
7:35 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2025
4:05 PM | Moleculin Biotech (Filer)
| Form DEF 14A | |
07/08/2025
4:06 PM | Moleculin Biotech (Filer)
| Form DEFA14A | |
06/27/2025
4:25 PM | Moleculin Biotech (Filer)
| Form PRE 14A | |
06/23/2025
3:34 PM | Moleculin Biotech (Issuer)
PICKER DONALD H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
3:35 PM | KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
3:35 PM | Foster Jonathan P. (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
8:19 AM | Moleculin Biotech (Filer)
| Form 424B4 | |
06/22/2025
11:15 PM | Moleculin Biotech (Filer)
| Form EFFECT | |
06/18/2025
8:00 PM | KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
8:01 PM | Foster Jonathan P. (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
6:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2025
3:19 PM | Moleculin Biotech (Filer)
| Form S-1/A | |
06/11/2025
4:30 PM | Moleculin Biotech (Filer)
| Form S-1/A | |
06/06/2025
8:20 AM | Moleculin Biotech (Filer)
| Form S-1/A | |
06/05/2025
10:01 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2025
7:45 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2025
4:15 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2025
4:24 PM | Moleculin Biotech (Filer)
| Form PRE 14A | |
05/15/2025
2:30 PM | ARMISTICE CAPITAL, LLC (Filed by)
Moleculin Biotech (Subject)
| Form SCHEDULE 13G/A | |
05/14/2025
6:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/12/2025
7:40 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2025
8:00 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2025
8:00 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/05/2025
7:45 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2025
7:35 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/21/2025
3:42 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2025
7:35 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/09/2025
3:31 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/07/2025
11:15 PM | Moleculin Biotech (Filer)
| Form EFFECT | |
The Coin That Could Define Trump’s Crypto Presidency (Ad) When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed.
While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.” Discover the coin that could define Trump’s crypto presidency. |
04/01/2025
7:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/31/2025
4:04 PM | Moleculin Biotech (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
03/24/2025
6:15 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/24/2025
6:05 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2025
3:30 PM | Moleculin Biotech (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/13/2025
4:15 PM | Moleculin Biotech (Filer)
| Form DEF 14A | |
03/13/2025
4:15 PM | Moleculin Biotech (Filer)
| Form DEF 14A | |
03/06/2025
7:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2025
9:09 AM | Moleculin Biotech (Filer)
| Form 424B5 | |
02/24/2025
4:16 PM | Moleculin Biotech (Filer)
| Form RW | |
02/14/2025
4:51 PM | ARMISTICE CAPITAL, LLC (Filed by)
Moleculin Biotech (Subject)
| Form SCHEDULE 13G/A | |
02/13/2025
3:17 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2025
8:25 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/11/2025
8:25 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/11/2025
7:31 AM | Moleculin Biotech (Filer)
| Form S-1/A | |
02/10/2025
7:32 AM | Moleculin Biotech (Filer)
| Form S-1/A | |
02/10/2025
7:33 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2025
8:18 AM | Moleculin Biotech (Filer)
| Form S-1/A | |
01/27/2025
11:08 AM | Moleculin Biotech (Filer)
| Form 8-K/A | |
01/27/2025
8:16 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/27/2025
7:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
7:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
7:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2024
7:15 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2024
4:02 PM | Moleculin Biotech (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
12/11/2024
7:15 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
11:15 PM | Moleculin Biotech (Filer)
| Form EFFECT | |
12/03/2024
4:20 PM | Moleculin Biotech (Filer)
| Form POS AM | |
11/18/2024
7:20 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
7:20 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
7:35 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
7:15 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
6:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
4:09 PM | Moleculin Biotech (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
7:00 PM | KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
7:00 PM | Foster Jonathan P. (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
7:03 PM | Moleculin Biotech (Issuer)
PICKER DONALD H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
7:03 PM | CANNON MICHAEL D (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
7:03 PM | George Robert E. (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
7:04 PM | Climaco John M (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
7:05 PM | Cermak Elizabeth (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
7:06 PM | Moleculin Biotech (Issuer)
Yan Joy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
4:27 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2024
3:43 PM | Moleculin Biotech (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
10/25/2024
3:16 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
7:40 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/07/2024
7:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2024
7:00 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/16/2024
7:31 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/16/2024
7:15 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
The Coin That Could Define Trump’s Crypto Presidency (Ad) When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed.
While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.” Discover the coin that could define Trump’s crypto presidency. |
09/09/2024
7:15 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/03/2024
4:15 PM | Moleculin Biotech (Filer)
| Form PRE 14A | |
MarketBeat All Access